Determining the appropriate number and duration of leech therapy in congested tissues using tissue spectrophotometry and laser Doppler flowmetry
Rothenberger J, Petersen W, Schaller HE, Held M (2016) · Wound Repair and Regeneration · n=12
Studienprofil
- Design
- single-center prospective observational study using tissue spectrophotometry and laser Doppler flowmetry to quantify perfusion dynamics during leech therapy (BG-Trauma Center, Eberhard Karls University Tuebingen, Germany)
- Stichprobengröße (n)
- 12
- Intervention
- Single leech application to venously congested tissues with serial Oxygen-to-See (O2C) device measurements of blood flow (BF), relative hemoglobin (rHB), and oxygen saturation (SO2) before and at 10 minutes, 1 hour, and 3 hours post-application
- Komparator
- No randomized comparator - within-subject repeated measurements over time
- Primärer Endpunkt
- Blood flow, relative hemoglobin, and oxygen saturation in congested tissues at 10 minutes, 1 hour, and 3 hours after leech application
- Primäres Ergebnis
- Significant improvements at 1 hour post-application: BF +56.7%, rHB -25.5%, SO2 +53.7%; values returned to baseline by 3 hours; further leech administration within measurement period produced no substantial additional perfusion change; authors propose the O2C device as a useful real-time guide for protocol optimization
- Follow-up-Dauer
- 3 hours per leech application episode
- PMID
- 27733014
Wichtigste Ergebnisse
- First study to quantify the time course of perfusion improvement in venously congested tissue after leech application using validated optical biosensors
- Significant perfusion improvement at 1 hour: blood flow +56.7%, relative hemoglobin -25.5%, oxygen saturation +53.7%
- Perfusion benefits returned to baseline by 3 hours - clinically meaningful for protocol timing
- Tissue spectrophotometry (O2C device) proposed as real-time guide to leech application protocol
- Provides objective biomarker confirmation of the venous-decongestion mechanism in microsurgical flap salvage
Einschränkungen
- Small sample (n=12) and single center
- Observational design without randomized comparator
- Short follow-up (3 hours) within each application episode
- Mechanism study rather than clinical outcome study
- O2C device not yet routinely available in many US plastic surgery units
Klinische Implikationen
Rothenberger 2016 provides objective biomarker confirmation that medicinal leech therapy produces measurable venous decongestion in clinically congested tissues. The time course (peak benefit at 1 hour, return to baseline by 3 hours) directly informs protocol timing recommendations - particularly the standard 4-12 hour rotation interval used in microsurgical flap salvage. For US clinicians, the study supports the mechanistic basis for leech therapy in venous congestion and provides a candidate biomarker (tissue spectrophotometry) that could improve protocol standardization in future trials.
Verwandte Studien
Medicinal leech therapy in venous congestion of microsurgical flaps: a randomized comparison with heparin pinprick scarification
Merlino G, Carbone S, Servillo G, Marletta DA (2020)
Adjunctive medicinal leech therapy for venous congestion in free flaps: a German multicenter randomized trial
Lehnhardt M, Daigeler A, Behr B, Schmidt SV, Wallner C (2021)
Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011)
Medicinal leeches for surgically uncorrectable venous congestion after free flap breast reconstruction
Pannucci CJ, Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Kovach SJ, Serletti JM, Wu LC (2014)